The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD

NCT05066633 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: Metoprolol Succinate
DRUG: Placebo

Sponsor

Medical University of Gdansk